SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-19-000056
Filing Date
2019-08-01
Accepted
2019-08-01 16:08:07
Documents
3
Period of Report
2019-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kearningsreleaseq22019.htm 8-K 27805
2 EXHIBIT 99.1 ex991earningsreleaseq22019.htm EX-99.1 99547
3 imagea02.jpg GRAPHIC 5087
  Complete submission text file 0000891293-19-000056.txt   135700
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 19992722
SIC: 2834 Pharmaceutical Preparations